This site is intended for health professionals only

GP practices could lose ‘significant’ income as minor surgery protection ends

by Costanza Pearce
29 July 2020

Share this article

GP practices could lose ‘significant’ income because they cannot restart corticosteroid joint injections when NHS England ends minor surgery income protection that has been in place during the Covid-19 pandemic.

NHS England has said it is time for GPs to restart routine services, however new guidance on corticosteroid joint injections has advised against these during the pandemic.

GPs warned this would leave them taking ‘a significant cut in income’ or resuming delivery of the injections against the guidance.

Earlier this month, NHS England outlined its plan for the ‘second phase’ of the general practice response to coronavirus, including that GPs should resume patient reviews and health checks.

The letter added that local commissioners should stop making monthly payments to practices for the minor surgery DES – which includes joint injections and had been maintained ‘in line with the previous year’s achievements’ since April – from 1 July.

Dr Hugh Reeve, a GP in Grange-over-Sands, Cumbria, told Management in Practice’s sister publication, Pulse, that ‘the implication is that in order to maintain income we have to restart [the injections]’.

However, recent guidance advised GPs to exercise caution over delivering corticosteroid joint injections during the coronavirus pandemic due to risks of immunosuppression.

The guidance, supported by multiple groups including the British Orthopaedic Association, the British Society of Rheumatology and the RCGP, said GPs should ‘only give steroid injections for severe symptoms and where there are no other options’.

It said: ‘During the coronavirus pandemic, clinicians need to give extra consideration as to whether the benefits outweigh the risks.

‘Giving a steroid injection to an asymptomatic patient who is carrying the virus could potentially put them at increased risk of an adverse outcome from the virus.’

It added that GPs must take ‘great care’ over patients who are ‘clinically extremely vulnerable’ to Covid-19.

It said: ‘Great care will need to be given to assessing and discussing the risks both of any immunosuppression resulting from the injection and also attending a clinical setting where higher levels of Covid-19 may be present.

‘The risks for these patients may outweigh the benefits so clinicians need to exercise great caution and explain the risks to the patients. ‘

Dr Steve Kell, GP partner at Larwood Health Partnership in Worksop, reiterated that stopping income protection implies practices should restart delivering the injections – or face a ‘direct cut in funding’ if they follow the guidance.

He said: ‘[NHS England’s letter] doesn’t say you must start again, what it says is that the support for it stops on the 30 June. 

‘So you either take quite a significant cut in income or you start minor surgery again at your own risk and at the patient’s risk. That’s not good enough.’

He added: ‘It feels like we’re having to make things up as we go along, sometimes despite the guidance.’ 

And Dr Kell told Pulse that he doesn’t ‘know many GPs who would be happy to do minor surgery involving local anaesthetic in full PPE when it can wait, but we need the support financially’.

Dr Reeve took to Twitter to express his frustration at the news.

However, North London GP Dr Richard Ma said he had resumed delivery of the injections in April.

In a Tweet, he said: ‘I think we waited as long as we could but there’s only so much painkillers can do.’

In April, NICE warned that GPs should advise patients with chronic obstructive pulmonary disease (COPD) not to self-start a course of corticosteroids or antibiotics if they develop symptoms of coronavirus.

However, last month the low-cost and widely available steroid Dexamethasone was found to cut Covid deaths in an intensive care trial.

A version of this story was first published by our sister title Pulse.